Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Acute Bacterial Skin And Skin Structure Infections Industry By 2029?

The market size for acute bacterial skin and skin structure infections has seen considerable growth over the past years. There is a projected growth from $11.75 billion in 2024 to $12.9 billion in 2025, translating to a compound annual growth rate (CAGR) of 9.7%. The substantial growth during the historical period can be credited to ingenuity within the healthcare industry, economic elements, patient demographic trends, advancements in diagnostic techniques, and innovation in clinical trials.

The market size of acute bacterial skin and skin structure infections is anticipated to expand significantly over the next few years, reaching $18.7 billion in 2029 with a compound annual growth rate (CAGR) of 9.7%. The expansion during this forecast period can be ascribed to a variety of global epidemiological factors, the advent of novel therapies in the market, advanced diagnostic tools, a patient-focused approach, and evolving treatment guidelines. Key trends throughout this projection period encompass changes in patient population demographics, concerns surrounding antibiotic resistance, advancements in treatment tactics, the widespread existence of methicillin-resistant staphylococcus aureus (mrsa), and an emphasis on outpatient care.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13282&type=smp

Which Growth Drivers Are Shaping The Acute Bacterial Skin And Skin Structure Infections Market Outlook?

The escalating incidence of skin disorders is anticipated to boost the expansion of the acute bacterial skin and skin structure infections market in the future. Skin infections signify ailments caused when foreign entities like bacteria, fungi, or viruses penetrate and proliferate within the skin, resulting in diverse symptoms and unease. The increasing number of skin infections necessitates a heightened demand for treatment methods, antibiotics, and novel therapies to tackle acute bacterial and skin structure infections, promising patients receive the finest care and results. For example, the World Health Organization – a Switzerland-based specialized agency of the United Nations – reported in March 2023 that about 1.8 billion people worldwide experience skin conditions at any given moment. Around 10% of them are Neglected Tropical Diseases (NTDs), with fungal infections accounting for 34% and bacterial infections comprising 23% of cases, often causing high mortality rates. Hence, the burgeoning incidence of skin disorders is predicted to stimulate the growth of the acute bacterial skin and skin structure infections market.

How Is The Global Acute Bacterial Skin And Skin Structure Infections Market Broken Down By Segment?

The acute bacterial skin and skin structure infectionsmarket covered in this report is segmented –

1) By Type Of Infection: Hospital-Acquired Acute Bacterial Skin And Skin Structure Infections; Community-Acquired Acute Bacterial Skin And Skin Structure Infections

2) By Active Ingredients: Delafloxacin; Vancomycin; Ceftaroline Fosamil; Oritavancin; Tedizolid; Daptomycin; Tigecycline; Linezolid; Other Active Ingredients

3) By Route Of Administration: Oral; Parenteral; Topical

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

5) By Application: Cellulitis; Abscess; Surgical Wounds; Traumatic Wound

Subsegments:

1) By Hospital-Acquired Acute Bacterial Skin And Skin Structure Infections (HABSSSIs): Surgical Site Infections; Catheter-Related Infections; Pressure Ulcers; Infections Related To Medical Devices

2) By Community-Acquired Acute Bacterial Skin And Skin Structure Infections (CABSSSIs): Cellulitis; Abscesses; Impetigo; Folliculitis; Wound Infections

Which Notable Trends Are Transforming The Acute Bacterial Skin And Skin Structure Infections Market Outlook?

In an attempt to be more competitive in the acute bacterial skin and skin structure infections market, leading companies are investing in the development of innovative single-dose treatments. One such innovation is Dalbonova, a single-dose 1500 mg treatment that promises convenience and efficacy, allowing patients to receive the desired outcomes with just one dosage. BDR Pharmaceuticals Internationals Pvt. Ltd., an Indian pharmaceutical company with a focus on API (active pharmaceutical ingredient) and formulation therapeutic segments, for instance, launched the Dalbonova injection for acute bacterial skin and skin structure infections (ABSSSI) in August 2023. This injection not only minimizes the exposure to diseases acquired in hospitals by eliminating the need for admission but is also effective against certain gram-positive microorganisms causing ABSSSI in patients across all age groups, including newborns.

Who Are The Primary Market Leaders In The Acute Bacterial Skin And Skin Structure Infections Market?

Major companies operating in the acute bacterial skin and skin structure infections market report are Pfizer Inc., AbbVie Inc., Novartis AG, Abbott Laboratories, Fresenius SE & Co. KGaA, GSK PLC, Takeda Pharmaceutical Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Menarini Group, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Aspen Pharmacare Holdings Limited, Lupin Limited, Zydus Lifesciences Limited, Eurofarma Laboratórios S.A., Glenmark Pharmaceuticals Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Alkem Laboratories Limited, Zhejiang Huahai Pharmaceutical Co. Ltd., Zhejiang Medicine Co. Ltd., Aurobindo Pharma Limited, Zhejiang Jingxin Pharmaceutical Co. Ltd., ACS Dobfar SpA, Melinta Therapeutics LLC, Shandong Luoxin Pharmaceutical Group Co. Ltd., Wakunaga Pharmaceutical Co. Ltd., Flynn Pharma Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/acute-bacterial-skin-and-skin-structure-infections-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Acute Bacterial Skin And Skin Structure Infections Market?

Asia-Pacific was the largest region in the acute bacterial skin and skin structure infections market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the acute bacterial skin and skin structure infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13282&type=smp

Browse Through More Reports Similar to the Global Acute Bacterial Skin And Skin Structure Infections Market 2025, By The Business Research Company

Antibacterial Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antibacterial-products-global-market-report

Bacterial And Plasmid Vector Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bacterial-and-plasmid-vector-global-market-report

Dna Based Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-based-skin-care-products-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model